We work Hard to get you posted with latest updates

http://We%20work%20Hard%20to%20get%20you%20posted%20with%20latest%20updates

Spend time learning about the different aspects of that topic from experts in the field.

AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy

Unwrap our new Directory

http://Unwrap%20our%20new%20Directory

Directory

Home
Pharma
Bio-Pharma
MedTech
Veterinary
Cosmetics
Food
.Clinical
.Tech
.edu
.gov
M&A
.VC

KLN-1010

Advertisement

cGxPJobs Banner

Eli Lilly to Acquire Kelonia for In Vivo CAR-T Breakthrough

INDIANAPOLIS and BOSTON, Mass., April 20, 2026 Eli Lilly and Company has announced a landmark agreement to acquire Kelonia...

By cGxPwire Editor
April 21, 2026

Read More

Advertisement

cGxPJobs

Recent Posts

01

Bio-Pharma

AbbVie Reports Positive Phase 2 Zumilokibart Atopic Dermatitis Results
October 1, 2026
02

Pharma

Takeda Reports Phase 3 Zasocitinib Psoriasis Results
October 1, 2026
03

.Clinical

Oncolytics Reports Pelareorep Data Supporting Immune Activation in Liver Cancer
October 1, 2026
04

Bio-Pharma

Boehringer Ingelheim Commits €500M to Health and Sustainability
October 1, 2026
05

.Clinical

Dyne Therapeutics Reports One-Year Z-Basivarsen Data in DM1
October 1, 2026

Advertisement

Copyright © 2026 cGxP.wire | Made by 3styler

Directory

Home
Pharma
Bio-Pharma
MedTech
Veterinary
Cosmetics
Food
.Clinical
.Tech
.edu
.gov
M&A
.VC

Start typing and press Enter to search

Loading Comments...

Write a Comment...

Email (Required)

Name (Required)

Website